Mitotan er blevet rapporteret at fremme metaboliseringen af warfarin ved hepatisk mikrosomal enzyminduktion, hvilket kan medføre behov for øget dosis af warfarin.
Mitotane has been reported to accelerate the metabolism of warfarin through hepatic microsomal enzyme induction, leading to an increase in dose requirements for warfarin.